Pure Global
NCT06374810

Does Conscious Connected Breathwork Reduce Symptoms of Anxiety?

Does Conscious Connected Breathwork Reduces Symptoms of Anxiety. A Quantitative Study Conducted in an Online Environment
Richard Blake·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anxiety
Drug/Device/Intervention
Conscious Connected Breathwork
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Richard Blake
Funder
California Institute of Integral Studies
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 21, 2023
End date
Dec 20, 2023
Enrollment
108 participants
Primary outcome

Changes in anxiety symptoms

Summary

The goal of this clinical trial is to test whether conscious connected breathwork reduces
 symptoms of anxiety in people with mild to severe anxiety symptoms, as measured by the Zung
 Self Rating Anxiety Scale.
 
 The main questions aims to answer:
 
 1. Does conscious connected breathwork reduce symptoms of anxiety?
 
 2. Does an increased frequency of self-practice lead to even greater reductions of anxiety
 symptoms.
 
 there is a comparison group: Researchers will compare whether people doing the breathwork to
 see if [insert effects].
 
 Participants will participate in 1, 90 minute breath workshop per week for 6 weeks. These
 sessions will be held on Zoom by 2 facilitators. Participants will also be given a 10 minute
 recording of a guided conscious connected breathwork session that they will be encouraged to
 complete daily.

ICD-10 classifications
Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06374810
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06374810 through Pure Global AI's free database. This phase not specified trial is sponsored by Richard Blake and is currently Completed. The study focuses on Anxiety. Target enrollment is 108 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.